SB 7, titled the Woman and Child Protection Act, focuses on expanding civil enforcement mechanisms and legal restrictions related to abortion, specifically the manufacture and distribution of abortion-inducing drugs. The bill creates a new Chapter 171A in the Health and Safety Code, prohibiting the manufacturing, mailing, delivering, prescribing, or providing of abortion-inducing drugs within Texas, with limited exceptions for medical emergencies, ectopic pregnancies, or miscarriages. It affirms that these actions are illegal regardless of whether the person is located inside or outside the state, if the impact occurs in Texas.
The bill establishes a qui tam enforcement mechanism that allows private individuals, excluding government officials, to file civil lawsuits against violators. If successful, the private litigant is entitled to injunctive relief, attorney’s fees, and statutory damages of at least $100,000 per violation. Defendants are not allowed to use many common legal defenses, including federal immunity, reliance on legal precedent, or constitutional challenges based on third-party rights. Courts are barred from hearing certain claims that challenge the law’s enforceability or constitutionality, and exclusive appellate jurisdiction is given to the newly created Fifteenth Court of Appeals.
SB 7 includes a severability clause, meaning if any portion of the law is struck down, the rest remains in effect. It also disallows class-action lawsuits and prohibits coordination between state officials and private enforcers, except for the filing of amicus briefs. The bill makes it clear that the state is not enforcing the law directly, which may be a legal strategy to avoid judicial review under federal constitutional protections.
In essence, SB 7 is modeled on and expands the approach used in Texas’s 2021 SB 8 (the “Heartbeat Act”) by using private civil enforcement to avoid constitutional scrutiny. It extends enforcement reach, limits judicial remedies, and sharply restricts access to medication abortion.